In Vitro Time-Kill of Common Ocular Pathogens with Besifloxacin Alone and in Combination with Benzalkonium Chloride

Background: Besifloxacin ophthalmic suspension 0.6% (w/v%) contains benzalkonium chloride (BAK) as a preservative. We evaluated the in vitro time-kill activity of besifloxacin, alone and in combination with BAK, against common bacteria implicated in ophthalmic infections. Methods: The activity of be...

Descripción completa

Detalles Bibliográficos
Autores principales: Blondeau, Joseph, DeCory, Heleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227847/
https://www.ncbi.nlm.nih.gov/pubmed/34072129
http://dx.doi.org/10.3390/ph14060517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227847/
https://www.ncbi.nlm.nih.gov/pubmed/34072129
http://dx.doi.org/10.3390/ph14060517

Ejemplares similares